Why Atrion Corporation’s (ATRI) Stock Is Up 4.69%

By Jenna Brashear
January 29, 2024
Featured Tickers:
ATRI

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Atrion Corporation before investing.

In this article, we go over a few key elements for understanding Atrion Corporation’s stock price such as:

  • Atrion Corporation’s current stock price and volume
  • Why Atrion Corporation’s stock price changed recently
  • Upgrades and downgrades for ATRI from analysts
  • ATRI’s stock price momentum as measured by its relative strength

About Atrion Corporation (ATRI)

Before we jump into Atrion Corporation’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Atrion Corporation (Atrion) is engaged in the development and manufacture of products for medical applications. The Company's medical products primarily serve the fluid delivery, cardiovascular and ophthalmology markets. It has developed a variety of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in fields, such as anesthesia and oncology. Atrion's cardiovascular product, Myocardial Protection System (MPS3), is a technology used in open-heart surgery that delivers fluids and medications, mixes critical drugs, and controls temperature and pressure. Its ophthalmic products include specialized medical devices that disinfect contact lenses. Atrion also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Its medical and non-medical products are manufactured at facilities in Florida, Alabama and Texas.

Want to learn more about Atrion Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Atrion Corporation.

Learn More About A+ Investor

Atrion Corporation’s Stock Price as of Market Close

As of January 29, 2024, 4:00 PM, CST, Atrion Corporation’s stock price was $335.00.

Atrion Corporation is up 4.69% from its previous closing price of $319.98.

During the last market session, Atrion Corporation’s stock traded between $319.98 and $319.98. Currently, there are 1.76 million shares of Atrion Corporation stock available for purchase.

Atrion Corporation’s price-earnings (P/E) ratio is currently at 26.5, which is low compared to the Medical Equipment, Supplies & Distribution industry median of 37. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Atrion Corporation Stock Price History

Atrion Corporation’s (ATRI) price is currently down 11.56% so far this month.

During the month of January, Atrion Corporation’s stock price has reached a high of $439.99 and a low of $308.30.

Over the last year, Atrion Corporation has hit prices as high as $700.87 and as low as $274.98. Year to date, Atrion Corporation’s stock is down 40.12%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Atrion Corporation Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of January 26, 2024, there were analysts who downgraded Atrion Corporation’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Atrion Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Atrion Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Atrion Corporation’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Atrion Corporation (ATRI) by visiting AAII Stock Evaluator.

Relative Price Strength of Atrion Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of January 26, 2024, Atrion Corporation has a weighted four-quarter relative price strength of -18.51%, which translates to a Momentum Score of 19 and is considered to be Very Weak.

Want to learn more about how Atrion Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Atrion Corporation Stock Price: Bottom Line

As of January 29, 2024, Atrion Corporation’s stock price is $335.00, which is up 4.69% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Atrion Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
Zweig Screen: 11.3% Compared to S&P 500
at only 6.9%

Gain Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.